Literature DB >> 21039995

Normal red blood cells partially decrease diepoxybutane-induced chromosome breakage in cultured lymphocytes from Fanconi anaemia patients.

B Porto1, R Sousa, I Malheiro, J Gaspar, J Rueff, C Gonçalves, J Barbot.   

Abstract

OBJECTIVES: Fanconi anaemia (FA) is a cancer-prone chromosome instability syndrome characterized by hypersensitivity to DNA cross-linking agents, such as diepoxybutane (DEB). Previous studies have shown that normal red blood cells (RBC) can protect cultured lymphocytes against chromosomal breaks induced by DEB. The present study was designed to analyse influence of RBCs from normal individuals on frequency of DEB-induced chromosome breaks in lymphocyte cultures from FA patients.
MATERIALS AND METHODS: A comparative study was performed between DEB-induced chromosome breaks in cultures of FA lymphocytes with either autologous or heterologous RBCs. A further comparative study was carried out between whole blood cultures from FA patients performed on two occasions, before and 1 week after transfusion of RBCs.
RESULTS: It was observed that normal RBCs compared to FA RBCs, partially reduced chromosome breaks in cultured FA lymphocytes. A significant reduction in DEB-induced breaks was also observed in FA cultured lymphocytes obtained 1 week after transfusion of RBCs, in comparison to those observed in the same patients before RBC transfusion.
CONCLUSIONS: This study shows that DEB-induced chromosome instability in FA lymphocytes is partially reduced by normal RBCs. This effect may have some clinical relevance in vivo, whenever FA patients receive a RBC transfusion.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039995      PMCID: PMC6496188          DOI: 10.1111/j.1365-2184.2010.00706.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  28 in total

1.  Modulating factors of individual sensitivity to diepoxybutane: chromosome aberrations induced in vitro in human lymphocytes.

Authors:  S Landi; I Ponzanelli; G Cipollini; G Frenzilli; A Luccini; C P Milillo; I Sbrana; R Barale
Journal:  Mutagenesis       Date:  1997-01       Impact factor: 3.000

2.  Formal genetics of Fanconi's anemia.

Authors:  T M Schroeder; D Tilgen; J Krüger; F Vogel
Journal:  Hum Genet       Date:  1976-06-29       Impact factor: 4.132

3.  International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity.

Authors:  A D Auerbach; A Rogatko; T M Schroeder-Kurth
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

4.  Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspects.

Authors:  G Fanconi
Journal:  Semin Hematol       Date:  1967-07       Impact factor: 3.851

5.  Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: further insights into the role for oxidative stress in Fanconi's anaemia phenotype.

Authors:  G Pagano
Journal:  Carcinogenesis       Date:  2000-05       Impact factor: 4.944

6.  Influence of erythrocyte glutathione S-transferase T1 on sister chromatid exchanges induced by diepoxybutane in cultured human lymphocytes.

Authors:  K Pelin; A Hirvonen; H Norppa
Journal:  Mutagenesis       Date:  1996-03       Impact factor: 3.000

7.  Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1.

Authors:  D X Lin; Y M Tang; Q Peng; S X Lu; C B Ambrosone; F F Kadlubar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-11       Impact factor: 4.254

Review 8.  Fanconi anaemia proteins: major roles in cell protection against oxidative damage.

Authors:  Giovanni Pagano; Hagop Youssoufian
Journal:  Bioessays       Date:  2003-06       Impact factor: 4.345

Review 9.  How the fanconi anemia pathway guards the genome.

Authors:  George-Lucian Moldovan; Alan D D'Andrea
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

Review 10.  Body iron metabolism and pathophysiology of iron overload.

Authors:  Yutaka Kohgo; Katsuya Ikuta; Takaaki Ohtake; Yoshihiro Torimoto; Junji Kato
Journal:  Int J Hematol       Date:  2008-07-02       Impact factor: 2.490

View more
  1 in total

1.  In Vivo Red Blood Cells/Plasma Partition Coefficient of Treosulfan and Its Active Monoepoxide in Rats.

Authors:  Michał Romański; Anna Zacharzewska; Artur Teżyk; Franciszek K Główka
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-10       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.